Last 12 months
Inside the activity.
0 purchase rows · 71 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 21 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 19 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2025 Filed Oct 28, 2025 20:15 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 1,251,909 | $9.00 | $11,267,181.00 |
DisclosureSEC source: 0001193125-25-253518 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 19,292,787 F5 · kind: On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 20:15 UTC | SaleCommon Stock, $0.01 par value | 1,251,909 | $9.00 | $11,267,181.00 |
DisclosureSEC source: 0001193125-25-253520 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 19,292,787 F2 · kind: On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 156,923 | $9.00 | $1,412,307.00 |
DisclosureSEC source: 0001193125-25-248271 · ownership.xml · nonDerivative · entry 6 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 386,284 F7 · kind: On October 21, 2025, JHW Iliad Holdings II LLC sold 156,923 Shares pursuant to an underwritten secondary offering. F2 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F3 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 1,497,018 | $9.00 | $13,473,162.00 |
DisclosureSEC source: 0001193125-25-248271 · ownership.xml · nonDerivative · entry 4 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 3,685,068 F6 · kind: On October 21, 2025, JHW Iliad Holdings LLC sold 1,497,018 Shares pursuant to an underwritten secondary offering. F2 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 8,346,059 | $9.00 | $75,114,531.00 |
DisclosureSEC source: 0001193125-25-248271 · ownership.xml · nonDerivative · entry 2 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 20,544,696 F5 · kind: On October 21, 2025, J.H. Whitney VII, L.P sold 8,346,059 Shares pursuant to an underwritten secondary offering. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 156,923 | $9.00 | $1,412,307.00 |
DisclosureSEC source: 0001193125-25-248274 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 386,284 F7 · kind: On October 21, 2025, JHW Iliad Holdings II LLC sold 156,923 Shares pursuant to an underwritten secondary offering. F2 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F3 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 1,497,018 | $9.00 | $13,473,162.00 |
DisclosureSEC source: 0001193125-25-248274 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 3,685,068 F6 · kind: On October 21, 2025, JHW Iliad Holdings LLC sold 1,497,018 Shares pursuant to an underwritten secondary offering. F2 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 16:06 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 8,346,059 | $9.00 | $75,114,531.00 |
DisclosureSEC source: 0001193125-25-248274 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 20,544,696 F5 · kind: On October 21, 2025, J.H. Whitney VII, L.P sold 8,346,059 Shares pursuant to an underwritten secondary offering. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 14:41 UTC | SaleCommon Stock, $0.01 par value | 8,346,059 | $9.00 | $75,114,531.00 |
DisclosureSEC source: 0001193125-25-248078 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 20,544,696 F2 · kind: On October 21, 2025, J.H. Whitney VII, L.P sold 8,346,059 Shares pursuant to an underwritten secondary offering. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| July 10, 2025 Filed Jul 12, 2025 01:14 UTC |
VIGANO PAUL R10% owner
|
OtherCommon Stock, $0.01 par value | 17,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095436 · ownership.xml · nonDerivative · entry 5 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,426,034 F6 · kind: In-kind distribution from PSA Iliad Holdings to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 10, 2025 Filed Jul 12, 2025 01:14 UTC |
VIGANO PAUL R10% owner
|
OtherCommon Stock, $0.01 par value | 64,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095436 · ownership.xml · nonDerivative · entry 3 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Healthcare Investment Holdings LLC Disclosed balance after: 15,523,809 F5 · kind: In-kind distribution from PSA Healthcare to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 10, 2025 Filed Jul 12, 2025 01:12 UTC |
WILLIAMS ROBERT M JR10% owner
|
OtherCommon Stock, $0.01 par value | 17,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095434 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,426,034 F6 · kind: In-kind distribution from PSA Iliad Holdings to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 10, 2025 Filed Jul 12, 2025 01:12 UTC |
WILLIAMS ROBERT M JR10% owner
|
OtherCommon Stock, $0.01 par value | 64,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095434 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Healthcare Investment Holdings LLC Disclosed balance after: 15,523,809 F5 · kind: In-kind distribution from PSA Healthcare to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| July 10, 2025 Filed Jul 12, 2025 01:17 UTC | OtherCommon Stock, $0.01 par value | 17,109 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095438 · ownership.xml · nonDerivative · entry 4 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,426,034 F3 · kind: In-kind distribution from PSA Iliad Holdings to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| July 10, 2025 Filed Jul 12, 2025 01:17 UTC | OtherCommon Stock, $0.01 par value | 64,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-095438 · ownership.xml · nonDerivative · entry 3 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PSA Healthcare Investment Holdings LLC Disclosed balance after: 15,523,809 F2 · kind: In-kind distribution from PSA Healthcare to its members. F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| June 13, 2025 Filed Jun 13, 2025 23:00 UTC |
Cunningham Patrick A.Chief Compliance Officer
|
SaleCommon Stock, par value $0.01 per share | 18,500 | $4.93 | $91,173.55 |
DisclosureSEC source: 0000950170-25-086431 · ownership.xml · nonDerivative · entry 1 Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,869 F1 · price: This transaction was executed in multiple trades during the day at prices ranging from $4.9201 to $4.9410. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 23:00 UTC |
Buckhalter MatthewChief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 11,188 | $5.72 | $63,958.44 |
DisclosureSEC source: 0000950170-25-084986 · ownership.xml · nonDerivative · entry 1 Buckhalter Matthew · CIK 0001983673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,057 F1 · price: This transaction was executed in multiple trades during the day at prices ranging from $5.70 to $5.75. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 23:00 UTC |
Stewart DeborahSVP, Chief Accounting Officer
|
SaleCommon Stock, par value $0.01 per share | 15,457 | $5.56 | $85,970.29 |
DisclosureSEC source: 0000950170-25-084985 · ownership.xml · nonDerivative · entry 1 Stewart Deborah · CIK 0001983702 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,396 F1 · price: This transaction was executed in multiple trades during the day at prices ranging from $5.55 to $5.60. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 15:43 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 750,000 | $5.20 | $3,900,000.00 |
DisclosureSEC source: 0000950170-25-085222 · ownership.xml · nonDerivative · entry 2 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 28,890,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holding LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 15:36 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 750,000 | $5.20 | $3,900,000.00 |
DisclosureSEC source: 0000950170-25-085215 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 28,890,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holding LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 15:45 UTC | SaleCommon Stock, $0.01 par value | 750,000 | $5.20 | $3,900,000.00 |
DisclosureSEC source: 0000950170-25-085224 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 28,890,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holding LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| June 05, 2025 Filed Jun 9, 2025 19:02 UTC |
Perchik JerryChief Legal Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083962 · ownership.xml · nonDerivative · entry 1 Perchik Jerry · CIK 0002020493 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,645 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Shaner JeffChief Executive Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 63,618 | $5.51 | $350,535.18 |
DisclosureSEC source: 0000950170-25-083958 · ownership.xml · nonDerivative · entry 2 Shaner Jeff · CIK 0001520693 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,477,639 F2 · shares: Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Shaner JeffChief Executive Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083958 · ownership.xml · nonDerivative · entry 1 Shaner Jeff · CIK 0001520693 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,541,257 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Reisz Edwin C.Chief Administrative Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 49,783 | $5.51 | $274,304.33 |
DisclosureSEC source: 0000950170-25-083959 · ownership.xml · nonDerivative · entry 2 Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,285,899 F2 · shares: Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Reisz Edwin C.Chief Administrative Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083959 · ownership.xml · nonDerivative · entry 1 Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,335,682 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Buckhalter MatthewChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 51,298 | $5.51 | $282,651.98 |
DisclosureSEC source: 0000950170-25-083957 · ownership.xml · nonDerivative · entry 2 Buckhalter Matthew · CIK 0001983673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,245 F2 · shares: Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Buckhalter MatthewChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083957 · ownership.xml · nonDerivative · entry 1 Buckhalter Matthew · CIK 0001983673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 552,543 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Cunningham Patrick A.Chief Compliance Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 45,759 | $5.51 | $252,132.09 |
DisclosureSEC source: 0000950170-25-083956 · ownership.xml · nonDerivative · entry 2 Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,369 F2 · shares: Represents shares withheld for payment of taxes on vesting of performance-based restricted stock units; not an open market transaction. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Cunningham Patrick A.Chief Compliance Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083956 · ownership.xml · nonDerivative · entry 1 Cunningham Patrick A. · CIK 0001858847 · Chief Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,128 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Stewart DeborahSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 47,029 | $5.51 | $259,129.79 |
DisclosureSEC source: 0000950170-25-083955 · ownership.xml · nonDerivative · entry 2 Stewart Deborah · CIK 0001983702 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,853 F2 · shares: Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 23:00 UTC |
Stewart DeborahSVP, Chief Accounting Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083955 · ownership.xml · nonDerivative · entry 1 Stewart Deborah · CIK 0001983702 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,882 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. Read SEC document |
| June 05, 2025 Filed Jul 16, 2025 23:00 UTC Amendment |
Reisz Edwin C.Chief Administrative Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 49,783 | $5.51 | $274,304.33 |
DisclosureSEC source: 0000950170-25-096375 · ownership.xml · nonDerivative · entry 2 Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371,497 F3 · shares: Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction. F2 · balance_after: This amended Form 4 is being filed solely to correct the inadvertent errors in the number of securities beneficially owned in Column 5 following each of the two reported transactions in Table I of the Form 4 filed on June 9, 2025 (the "Original Form 4"). All other information reported in the Original Form 4 remains the same. Read SEC document |
| June 05, 2025 Filed Jul 16, 2025 23:00 UTC Amendment |
Reisz Edwin C.Chief Administrative Officer
|
GrantCommon Stock, par value $0.01 per share | 139,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-096375 · ownership.xml · nonDerivative · entry 1 Reisz Edwin C. · CIK 0001859462 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421,280 F1 · shares: Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan. F2 · balance_after: This amended Form 4 is being filed solely to correct the inadvertent errors in the number of securities beneficially owned in Column 5 following each of the two reported transactions in Table I of the Form 4 filed on June 9, 2025 (the "Original Form 4"). All other information reported in the Original Form 4 remains the same. Read SEC document |
| May 19, 2025 Filed May 21, 2025 14:11 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 1,560,700 | $5.36 | $8,365,352.00 |
DisclosureSEC source: 0000950170-25-075601 · ownership.xml · nonDerivative · entry 2 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 29,640,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 19, 2025 Filed May 21, 2025 14:12 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 1,560,700 | $5.36 | $8,365,352.00 |
DisclosureSEC source: 0000950170-25-075602 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 29,640,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 19, 2025 Filed May 21, 2025 14:13 UTC | SaleCommon Stock, $0.01 par value | 1,560,700 | $5.36 | $8,365,352.00 |
DisclosureSEC source: 0000950170-25-075604 · ownership.xml · nonDerivative · entry 2 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 29,640,756 F1 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 528 | $5.89 | $3,109.92 |
DisclosureSEC source: 0000950170-25-073469 · ownership.xml · nonDerivative · entry 11 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 543,207 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 1,403 | $5.89 | $8,263.67 |
DisclosureSEC source: 0000950170-25-073469 · ownership.xml · nonDerivative · entry 9 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,443,143 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 5,039 | $5.89 | $29,679.71 |
DisclosureSEC source: 0000950170-25-073469 · ownership.xml · nonDerivative · entry 7 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,182,086 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 15,158 | $5.89 | $89,280.62 |
DisclosureSEC source: 0000950170-25-073469 · ownership.xml · nonDerivative · entry 5 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,588,582 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:37 UTC |
VIGANO PAUL R10% owner
|
SaleCommon Stock, $0.01 par value | 30,340 | $5.89 | $178,702.60 |
DisclosureSEC source: 0000950170-25-073469 · ownership.xml · nonDerivative · entry 3 VIGANO PAUL R · CIK 0001239606 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,201,456 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:54 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 528 | $5.89 | $3,109.92 |
DisclosureSEC source: 0000950170-25-073492 · ownership.xml · nonDerivative · entry 11 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 543,207 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:54 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 1,403 | $5.89 | $8,263.67 |
DisclosureSEC source: 0000950170-25-073492 · ownership.xml · nonDerivative · entry 9 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,443,143 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:54 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 5,039 | $5.89 | $29,679.71 |
DisclosureSEC source: 0000950170-25-073492 · ownership.xml · nonDerivative · entry 7 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,182,086 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:54 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 15,158 | $5.89 | $89,280.62 |
DisclosureSEC source: 0000950170-25-073492 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,588,582 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:54 UTC |
WILLIAMS ROBERT M JR10% owner
|
SaleCommon Stock, $0.01 par value | 30,340 | $5.89 | $178,702.60 |
DisclosureSEC source: 0000950170-25-073492 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,201,456 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 15, 2025 Filed May 16, 2025 19:41 UTC | SaleCommon Stock, $0.01 par value | 1,403 | $5.89 | $8,263.67 |
DisclosureSEC source: 0000950170-25-073478 · ownership.xml · nonDerivative · entry 7 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,443,143 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| May 15, 2025 Filed May 16, 2025 19:41 UTC | SaleCommon Stock, $0.01 par value | 15,158 | $5.89 | $89,280.62 |
DisclosureSEC source: 0000950170-25-073478 · ownership.xml · nonDerivative · entry 5 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,588,582 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
|
| May 15, 2025 Filed May 16, 2025 19:41 UTC | SaleCommon Stock, $0.01 par value | 30,340 | $5.89 | $178,702.60 |
DisclosureSEC source: 0000950170-25-073478 · ownership.xml · nonDerivative · entry 3 J.H. Whitney Equity Partners VII, LLC · CIK 0001567459 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,201,456 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.96. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.